Article
Glycogen synthase kinase-3β (GSK3β) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice
Department of Pediatric Dentistry, University of Alabama at Birmingham, Birmingham, AL 35294, United States; Department of Microbiology, University of Alabama at Birmingham, 845 19th Street South, BBRB 258/5, Birmingham, AL 35294-2170, United States
Molecular Immunology
DOI:10.1016/j.molimm.2008.08.281
-
Citations (0)
- Cited In (1)
-
Article: Kinase activity profiling of pneumococcal pneumonia.
[show abstract] [hide abstract]
ABSTRACT: Pneumonia represents a major health burden. Previous work demonstrated that although the induction of inflammation is important for adequate host defense against pneumonia, an inability to regulate the host's inflammatory response within the lung later during infection can be detrimental. Intracellular signaling pathways commonly rely on activation of kinases, and kinases play an essential role in the regulation of the inflammatory response of immune cells. Pneumonia was induced in mice via intranasal instillation of Streptococcus (S.) pneumoniae. Kinomics peptide arrays, exhibiting 1024 specific consensus sequences for protein kinases, were used to produce a systems biology analysis of cellular kinase activity during the course of pneumonia. Several differences in kinase activity revealed by the arrays were validated in lung homogenates of individual mice using western blot. We identified cascades of activated kinases showing that chemotoxic stress and a T helper 1 response were induced during the course of pneumococcal pneumonia. In addition, our data point to a reduction in WNT activity in lungs of S. pneumoniae infected mice. Moreover, this study demonstrated a reduction in overall CDK activity implying alterations in cell cycle biology. This study utilizes systems biology to provide insight into the signaling events occurring during lung infection with the common cause of community acquired pneumonia, and may assist in identifying novel therapeutic targets in the treatment of bacterial pneumonia.PLoS ONE 01/2011; 6(4):e18519. · 4.09 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
anti-inflammatory cytokine IL-10
bioterrorism agent
causative agent
F. tularensis LVS
F. tularensis LVS infection
F. tularensis LVS-induced cytokine response
F. tularensis results
Glycogen synthase kinase-3β
GSK3β inhibition
IFN-γ potentiated F. tularensis LVS-induced cytokine production
infected animals
key regulatory
modulating inflammatory responses
murine peritoneal macrophages induced
novel therapeutic approach
pro-inflammatory cytokine IL-6
serine/threonine protein kinase
significant decrease
TLR2 dependent phosphorylation
transcription factors NF-κB